Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?
about
Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamineAntidepressants upregulate messenger RNA levels of the neuroprotective enzyme superoxide dismutase (SOD1)Abnormalities in brain structure and behavior in GSK-3alpha mutant micePrefrontal cortical-amygdalar metabolism in major depression.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder.Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms.The combined dexamethasone/CRH Test (DEX/CRH test) and prediction of acute treatment response in major depressionDisrupting hypothalamic glucocorticoid receptors causes HPA axis hyperactivity and excess adipositySecond messenger-regulated protein kinases in the brain: their functional role and the action of antidepressant drugs.Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus.Chronic pain, chronic stress and depression: coincidence or consequence?Developmental fluoxetine exposure normalizes the long-term effects of maternal stress on post-operative pain in Sprague-Dawley rat offspring.Enduring good memories of infant trauma: rescue of adult neurobehavioral deficits via amygdala serotonin and corticosterone interaction.Cortisol and depressive symptoms in a population-based cohort of midlife women.Maternal depression and anxiety are associated with altered gene expression in the human placenta without modification by antidepressant use: implications for fetal programmingOf sound mind and body: depression, disease, and accelerated agingDysfunctional neurotransmitter systems in fibromyalgia, their role in central stress circuitry and pharmacological actions on these systemsImplication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depressionThe role of dietary polyphenols on adult hippocampal neurogenesis: molecular mechanisms and behavioural effects on depression and anxietyCandidate genes for antidepressant response to selective serotonin reuptake inhibitorsNeuroendocrinological mechanisms of actions of antidepressant drugs.Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure.The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression.Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models.Temporal variability of glucocorticoid receptor activity is functionally important for the therapeutic action of fluoxetine in the hippocampus.Developmental changes in serotonin signaling: Implications for early brain function, behavior and adaptationRole of mineralocorticoid receptors on the hypothalamus-pituitary-adrenal axis in humans.Perinatal maternal stress and serotonin signaling: effects on pain sensitivity in offspring.Influence of genetic polymorphisms involved in the hypothalamic-pituitary-adrenal axis and their interactions with environmental factors on antidepressant response.Tryptophan: the key to boosting brain serotonin synthesis in depressive illness.Differential effects of antidepressants on glucocorticoid receptors in human primary blood cells and human monocytic U-937 cells.Depressive illness and the possibilities of somatic antidepressant treatment.St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.Limitations to enhancing the speed of onset of antidepressants - are rapid action antidepressants possible?The Role of the Endocannabinoids in Suppression of the Hypothalamic-pituitary-adrenal Axis Activity by Doxepin.Imipramine-induced c-Fos expression in the medial prefrontal cortex is decreased in the ACTH-treated rats.Treatment of abdominally obese men with a serotonin reuptake inhibitor: a pilot study.Chronic antidepressant treatments decrease pro-opiomelanocortin mRNA expression in the pituitary gland: effects of acute stress and 5-HT(1A) receptor activation.Fluvoxamine reduces responsiveness of HPA axis in adult female BPD patients with a history of sustained childhood abuse.Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine.
P2860
Q24685198-A54C5840-A310-4157-9F00-48AABAD2BE0CQ28344028-C4F6F1FA-8C00-49A1-B660-134DC299B6D6Q30485018-F35EAFF8-B029-4689-81FD-15403DE38E9EQ30579598-479F1786-7154-450F-897F-559230DE5954Q31121208-B9D10D9B-AD03-494B-A053-E0C2ACAA5932Q31156853-13C72C86-39ED-4F31-9F03-71F0E575D9C6Q33403748-24C174F4-4965-4EC8-8322-DAE2DBC235A1Q33770354-36FE4539-AB1D-4BDE-832D-34885E2378D7Q33806945-327E45C9-AC9E-458B-A00E-E52F29046DBCQ33926970-AD7A0C5B-5AB0-4D2F-BB00-4E6927CA0D0BQ34448514-91CB4065-6EC6-4703-ADC6-09F3ED2B2812Q34600630-3A946457-7178-499D-BE4A-A43441456ABAQ35031333-B9DED4DE-B02B-4768-8221-420D48A5BD14Q35047288-7065BBC2-FC35-44AE-A506-3ADFCF99185AQ35161157-023FE535-1999-477C-8505-2921816ABE9BQ35237227-65D57A7F-0C77-452D-A73D-20327F3556E8Q35374174-3C86C51C-9C67-42E2-A4A7-833C09390493Q35790395-D326B308-C7DA-4107-9E39-CC851CCD4939Q36090823-DFC289DD-74C9-4230-9451-3029379FFF35Q36718053-E27BAB84-41B5-4D86-8FFB-6DA2234FC06BQ36728947-F57FCC88-2A54-4490-8F9B-9E045AEC929BQ36766378-F53ADA88-4E74-45C6-B612-A798E8CC0816Q36787614-617FCB2C-CA4E-429B-AAB2-3E016D3E04C4Q37035595-83A75C04-8394-4A0A-B36A-BE324E25C162Q37536291-6C7CBB64-230D-4032-BAE0-929D63B384B1Q37643389-BF782C1E-364C-4A1E-9CDA-954EE20F85FAQ38029960-AD5CD8D7-0487-4E72-9AB0-C140E58A9726Q38169120-AB3FA00C-BE90-4B94-866E-9D95093E2A2BQ39034597-45CA2D67-697C-456E-B642-424167869E68Q39374641-593B193C-B213-4100-BC21-86589DFC9D61Q40661639-F31F6D10-A64F-475E-95EF-F1EEA025124FQ41459287-305133EC-3224-4D06-970E-2B80193A7CC0Q42658073-A22215AB-0E9D-48B7-A9D2-90146ECEAB3CQ42686822-D9BA96F3-1F6F-4A64-B946-0133FF500C09Q42917343-566BDEB5-0070-4DFE-83C3-4E8403F2BAD7Q43542890-4903A67D-F330-47D4-A127-F9FA05B768DFQ43736096-B9A70C6D-EF6A-4155-9270-C15C3C0712B5Q43778529-F42628E5-1AD6-4EEB-BC3A-3690AF3A6989Q44259236-B3FF2372-3DC5-4255-A170-A0316A79CCDBQ44293193-FA6FE3F4-BD4F-4B27-A17E-AB45D9215C22
P2860
Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Do antidepressants stabilize m ...... tuitary-adrenocortical system?
@en
type
label
Do antidepressants stabilize m ...... tuitary-adrenocortical system?
@en
prefLabel
Do antidepressants stabilize m ...... tuitary-adrenocortical system?
@en
P1476
Do antidepressants stabilize m ...... tuitary-adrenocortical system?
@en
P2093
P356
10.1016/0166-2236(95)93942-Q
P577
1995-01-01T00:00:00Z